ACADIA Pharmaceuticals Inc (ACAD)

Add to Watchlists
Create an Alert
26.25 -0.97  -3.56% NASDAQ Mar 22, 14:18 Delayed 2m USD
View Full Chart
ACAD Price Chart
View All Events

ACAD Events

Date Type Description
05/03/2019 08:30 EDT Misc ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019
05/03/2019 Earnings ACADIA Pharmaceuticals Inc First Quarter Earnings in 2019 Release
02/27/2019 Misc ACADIA Pharmaceuticals Inc Annual Report in 2018
02/26/2019 17:00 EST Misc ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
02/26/2019 Earnings ACADIA Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release
11/06/2018 17:00 EST Misc ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018
11/06/2018 Earnings ACADIA Pharmaceuticals Inc Third Quarter Earnings in 2018 Release
08/08/2018 17:00 EDT Misc ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018
08/08/2018 Earnings ACADIA Pharmaceuticals Inc Second Quarter Earnings Results in 2018
06/06/2018 Misc ACADIA Pharmaceuticals Inc Annual General Meeting in 2017
View All Performance Charts

ACAD Total Returns Comparison

Advertisement

ACAD One Page Reports

Edit

Profile

  • URL: http://www.acadia-pharm.com
  • Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: May. 03, 2019
  • Last Earnings Release: Feb. 26, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

ACAD Comparables

Edit

ACAD Excel Add-In Codes

  • Name: =YCI("ACAD","name")
  • Description: =YCI("ACAD","description")
  • Sector: =YCI("ACAD","sector")
  • Industry: =YCI("ACAD","industry")
  • Est. Current Fiscal Year End: =YCI("ACAD","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.